https://codeblue.galencentre.org/2022/10/31/cancer-drug-price-negotiations-to-focus-on-generics-biosimilars/
0
0
37 words
0
Comments
The UICC and WHO will negotiate for cheaper cancer drugs for low and low-middle-income countries via increased donations, tier pricing, or a voluntary licence mechanism.
You are the first to view
Create an account or login to join the discussion